BPMC News and Press, Blueprint Medicines Corporation From 09/02/21

Blueprint Medicines to Present at Morgan Stanley 19th Annual Global Healthcare Conference PR Newswire CAMBRIDGE, Mass. , Sept. 2, 2021 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC) today announced that Kate Haviland , Blueprint Medici...

Speaking back in May on his company's Q1 2021 earnings call, Pfizer (NYSE: PFE) CEO Albert Bourla stated, "You should expect to see a lot of ... business development deals that will allow us to bring in-house a lot of potential medicines that could become [approved treatments] ... i...

Blueprint Medicines Corporation (BPMC) Q2 2021 Earnings Conference Call July 29, 2021 08:30 AM ET Company Participants Kristin Hodous - Senior Manager-Investor Relations Jeff Albers - Chief Executive Officer Christy Rossi - Chief Commercial Officer Becker Hewes - Chief Medical Officer Mike La...

Blueprint Medicines  (NASDAQ:BPMC): Q2 GAAP EPS of -$1.86 misses by $0.05. Revenue of $27.3M (+227.3% Y/Y) beats by $9.69M. As of June 30, 2021, cash, cash equivalents and investments were $1,380.1M, as compared to $1,549.7M as of December 31, 2020.  Press Release For further deta...

Blueprint Medicines Reports Second Quarter 2021 Financial Results -- Obtained FDA approval and launched AYVAKIT™ (avapritinib) for advanced systemic mastocytosis -- -- Expect topline data from Part 2 of registration-enabling Phase 2 PIONEER trial of AYVAKIT in non-adv...

MD Anderson and Blueprint Medicines Announce Strategic Collaboration to Accelerate BLU-222 Development Translational research will focus on advancing therapeutic strategies for Blueprint Medicines' potent and selective CDK2 inhibitor across a broad range of tumor types PR Ne...

Blueprint Medicines to Report Second Quarter 2021 Financial Results on Thursday, July 29, 2021 PR Newswire CAMBRIDGE, Mass. , July 22, 2021 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC), today announced that it will host a live conference ca...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips It’s been a big quarter for biotech stocks. Biogen (NASDAQ: BIIB ) had a major breakthrough with the approval of its Alzheimer’s vaccine aducanumab, which is sold under the brand name Aduhelm. It mar...

Today, we take an in-depth look at Blueprint Medicines Corporation. The company just obtained a FDA approval and also had several analyst firm buy rating reiterations last week. A full investment analysis is presented in the paragraphs below. For further details see: Blu...

Halvorsen's 13F portfolio value decreased from $36.37B to $33.58B. The number of positions decreased from 96 to 94. Viking Global added Bank of America while reducing JPMorgan Chase and dropping Walt Disney. The top three positions are Microsoft, BridgeBio Pharma, and Fidelity Nat...